These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16413713)

  • 21. Micellar aggregates of saponins from Chenopodium quinoa: characterization by dynamic light scattering and transmission electron microscopy.
    Verza SG; de Resende PE; Kaiser S; Quirici L; Teixeira HF; Gosmann G; Ferreira F; Ortega GG
    Pharmazie; 2012 Apr; 67(4):288-92. PubMed ID: 22570933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery.
    Maestrelli F; González-Rodríguez ML; Rabasco AM; Mura P
    Int J Pharm; 2006 Apr; 312(1-2):53-60. PubMed ID: 16469460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of antibody and T-cell responses by immunization with ISCOMS containing the 38-kilodalton protein of Mycobacterium tuberculosis.
    da Fonseca DP; Frerichs J; Singh M; Snippe H; Verheul AF
    Vaccine; 2000 Aug; 19(1):122-31. PubMed ID: 10924794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virosome and ISCOM vaccines against Newcastle disease: preparation, characterization and immunogenicity.
    Homhuan A; Prakongpan S; Poomvises P; Maas RA; Crommelin DJ; Kersten GF; Jiskoot W
    Eur J Pharm Sci; 2004 Aug; 22(5):459-68. PubMed ID: 15265516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of Quil A-phospholipid mixtures using drift spectroscopy.
    Demana PH; Davies NM; Hook S; Rades T
    Int J Pharm; 2007 Sep; 342(1-2):49-61. PubMed ID: 17555894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of carbohydrate modification of Quillaja saponaria Molina QH-B fraction on adjuvant activity, cholesterol-binding capacity and toxicity.
    Rönnberg B; Fekadu M; Behboudi S; Kenne L; Morein B
    Vaccine; 1997 Dec; 15(17-18):1820-6. PubMed ID: 9413088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mannosylated saponins based on oleanolic and glycyrrhizic acids. Towards synthetic colloidal antigen delivery systems.
    Daines AM; Greatrex BW; Hayman CM; Hook SM; McBurney WT; Rades T; Rendle PM; Sims IM
    Bioorg Med Chem; 2009 Jul; 17(14):5207-18. PubMed ID: 19502067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liposomes and ISCOMs.
    Kersten GF; Crommelin DJ
    Vaccine; 2003 Feb; 21(9-10):915-20. PubMed ID: 12547602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quaternary structure of the immunostimulating complex (iscom).
    Ozel M; Höglund S; Gelderblom HR; Morein B
    J Ultrastruct Mol Struct Res; 1989 Dec; 102(3):240-8. PubMed ID: 2634709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvanticity and ISCOM formation by structurally diverse saponins.
    Bomford R; Stapleton M; Winsor S; Beesley JE; Jessup EA; Price KR; Fenwick GR
    Vaccine; 1992; 10(9):572-7. PubMed ID: 1502835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation and in vitro evaluation of liposomal chloroquine diphosphate loaded by a transmembrane pH-gradient method.
    Qiu L; Jing N; Jin Y
    Int J Pharm; 2008 Sep; 361(1-2):56-63. PubMed ID: 18573626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cationic liposome (DC-Chol/DOPE=1:2) and a modified ethanol injection method to prepare liposomes, increased gene expression.
    Maitani Y; Igarashi S; Sato M; Hattori Y
    Int J Pharm; 2007 Sep; 342(1-2):33-9. PubMed ID: 17566677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro cutaneous application of ISCOMs on human skin enhances delivery of hydrophobic model compounds through the stratum corneum.
    Madsen HB; Ifversen P; Madsen F; Brodin B; Hausser I; Nielsen HM
    AAPS J; 2009 Dec; 11(4):728-39. PubMed ID: 19862629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mathematical modelling of preparation of acyclovir liposomes: reverse phase evaporation method.
    Seth AK; Misra A
    J Pharm Pharm Sci; 2002; 5(3):285-91. PubMed ID: 12553898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of soybean phosphatidylcholine-chitosan nanovesicles by reverse phase evaporation: a step by step study.
    Mertins O; Sebben M; Pohlmann AR; da Silveira NP
    Chem Phys Lipids; 2005 Dec; 138(1-2):29-37. PubMed ID: 16144696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ISCOMs (immunostimulating complexes): the first decade.
    Barr IG; Mitchell GF
    Immunol Cell Biol; 1996 Feb; 74(1):8-25. PubMed ID: 8934649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study on preparation technology of aconitine liposomes].
    Dong WW; Zhang YF; Liu XP; Geng DQ
    Zhong Yao Cai; 2008 Sep; 31(9):1413-5. PubMed ID: 19180972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influenza virus ISCOMs: biochemical characterization.
    Sundquist B; Lövgren K; Höglund S; Morein B
    Vaccine; 1988 Feb; 6(1):44-8. PubMed ID: 3354257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ISCOMs: an adjuvant with multiple functions.
    Sjölander A; Cox JC; Barr IG
    J Leukoc Biol; 1998 Dec; 64(6):713-23. PubMed ID: 9850152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunopotentiation of synthetic oligopeptides by chemical conjugation to iscoms.
    Larsson M; Lövgren K; Morein B
    J Immunol Methods; 1993 Jun; 162(2):257-60. PubMed ID: 8315292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.